Enanta Pharma GAAP EPS of -$1.63 misses by $0.20, revenue of $18.72M misses by $1.95M

• Enanta Pharma press release (NASDAQ:ENTA): Q2 GAAP EPS of -$1.63 misses by $0.20.
• Revenue of $18.72M (-7.0% Y/Y) misses by $1.95M.